IP Library › Granted Patent US 11,499,177
Granted Patent B2
US 11,499,177 · App. 16/490,100 · Granted Nov 15, 2022

Horseshoe crab factor B variant

Inventors: Yuki Kobayashi (Tokyo, JP); Hikaru Mizumura (Tokyo, JP); Toshio Oda (Tokyo, JP); Shun-Ichiro Kawabata (Fukuoka, JP)
Assignee: SEIKAGAKU CORPORATION
C12Q1/37C12N9/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,499,177
App. No.
16/490,100
Granted
Nov 15, 2022
Kind
B2
Abstract

Provided is a technology related to a horseshoe crab factor B variant, and also provided is means for performing endotoxin measurement with high sensitivity. A polypeptide having an amino acid sequence in which the amino acid residue at the 193-position in an amino acid sequence of a polypeptide of horseshoe crab factor B is substituted with a cysteine (Cys) residue, is produced. Endotoxin measurement can be carried out with high sensitivity by configuring a Limulus reagent by combining this polypeptide with horseshoe crab factor C.

Claims (23)

1. A polypeptide represented by any one of the following (A) to (C):

(A) a polypeptide having an amino acid sequence represented by the following (A1) or (A2):

(A1) an amino acid sequence represented by amino acid numbers 1 to 400 of SEQ ID NO: 10; and

(A2) an amino acid sequence represented by amino acid numbers 24 to 400 of SEQ ID NO: 10,

(B) a polypeptide having an amino acid sequence including substitution, deletion, insertion, and/or addition of one amino acid residue or a plurality of amino acid residues in the amino acid sequence of the polypeptide represented by the item (A), provided that the cysteine (Cys) residue at the 193-position is neither substituted nor deleted, and having an identity of at least 90% to at least one of the amino acid sequences of the polypeptides represented by item (A), and the polypeptide having the function of horseshoe crab factor B, and

(C) a fusion polypeptide in which a peptide tag is added to the polypeptide represented by any one of the items (A) to (B), the polypeptide having the function of horseshoe crab factor B,

wherein the function of horseshoe crab factor B is to be activated in contact with an activated horseshoe crab factor C, and cleaving a horseshoe crab proclotting enzyme.

2. A nucleic acid encoding the polypeptide according to claim 1 .

3. A DNA encoding the polypeptide of claim 1 , said DNA represented by any one of the following (a) to (b):

(a) a DNA having a base sequence represented by any one of the following (a1) to (a4):

(a1) the base sequence represented by base numbers 1 to 1200 of SEQ ID NO: 8;

(a2) the base sequence represented by base numbers 70 to 1200 of SEQ ID NO: 8;

(a3) the base sequence represented by base numbers 1 to 1200 of SEQ ID NO: 9; and

(a4) the base sequence represented by base numbers 70 to 1200 of SEQ ID NO: 9,

(b) a DNA having the base sequence of a fusion DNA in which a peptide tag-encoding DNA is added to the DNA represented by any one of the items (a), the DNA encoding a polypeptide having the function of horseshoe crab factor B.

4. A vector retaining the nucleic acid according to claim 2 .

5. A cell retaining the nucleic acid according to claim 1 .

6. A method for producing a polypeptide, the method comprising a step of producing a polypeptide having the function of horseshoe crab factor B using the cell according to claim 5 .

7. A method for measuring an endotoxin, the method comprising steps of the following (1) and (2):

(1) a step of mixing the polypeptide according to claim 1 with horseshoe crab factor C and a test sample; and

(2) a step of measuring protease activity of the polypeptide.

8. A reagent for endotoxin measurement, the reagent comprising the polypeptide according to claim 1 as a constituent component.

9. A kit for endotoxin measurement, the kit comprising the polypeptide according to claim 1 , as a component part.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2019
From: KOBAYASHI, YUKI; MIZUMURA, HIKARU; ODA, TOSHIO; KAWABATA, SHUN-ICHIRO
To: SEIKAGAKU CORPORATION
Reel/Frame 050224/0882 →
Priority Claims (1)
JP JP2017-038692 · Mar 1, 2017 · national
Continuity (1)
Related Publication 20210363564A1 · Nov 25, 2021
Cited By (1)
US 12,540,944